Analyst Rating Changes — Upgrades, Downgrades & Price Targets

46586 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Sep 04 00:56 UTC	RARE Ultragenyx Pharmaceutical	◎ Target	HC Wainwright	Raghuram Selvaraju not yet tracked	Buy	$50.00→ $25.00-50.0%
Sep 04 00:56 UTC	RARE Ultragenyx Pharmaceutical	◎ Target	Wedbush	Laura Chico ★☆☆☆☆ #3101	Neutral	$30.00→ $23.00-23.3%
Sep 04 00:56 UTC	RARE Ultragenyx Pharmaceutical	◎ Target	Canaccord Genuity Group	Whitney Ijem ★☆☆☆☆ #3092	Buy	$83.00→ $37.00-55.4%
Sep 04 00:56 UTC	RARE Ultragenyx Pharmaceutical	◎ Target	Cantor Fitzgerald	Kristen Kluska ★☆☆☆☆ #3182	Overweight	$103.00→ $33.00-68.0%
Sep 04 00:56 UTC	RARE Ultragenyx Pharmaceutical	◎ Target	Citigroup	Yigal Nochomovitz ★☆☆☆☆ #3043	Buy	$58.00→ $28.00-51.7%
Sep 04 00:56 UTC	RARE Ultragenyx Pharmaceutical	◎ Target	TD Cowen	Yaron Werber ★☆☆☆☆ #2984	Buy	$49.00→ $18.00-63.3%
Sep 04 00:56 UTC	PVH PVH	◎ Target	Needham & Company LLC	Tom Nikic ★★☆☆☆ #2453	Buy	$102.00→ $95.00-6.9%
Sep 04 00:56 UTC	PVH PVH	◎ Target	JPMorgan Chase & Co.	Matthew Boss ★★☆☆☆ #2558	Underweight	$84.00→ $83.00-1.2%
Sep 04 00:56 UTC	PSX Phillips 66	◎ Target	Piper Sandler	John Royall not yet tracked	Neutral	$209.00→ $264.00+26.3%
Sep 04 00:56 UTC	PS Pershing Square	◎ Target	Wells Fargo & Company	Robert Ryan not yet tracked	Equal Weight	$34.00→ $36.00+5.9%
Sep 04 00:56 UTC	PS Pershing Square	◎ Target	Tigress Financial	Ivan Feinseth ★★★☆☆ #1344	Neutral	$39.00→ $41.00+5.1%
Sep 04 00:56 UTC	PLTK Playtika	◎ Target	Citigroup	Jason Bazinet ★★☆☆☆ #2722	Buy	$4.50→ $4.00-11.1%
Sep 04 00:56 UTC	PHR Phreesia	◎ Target	Wells Fargo & Company	Stan Berenshteyn ★★★☆☆ #1554	Equal Weight	$9.00→ $10.00+11.1%
Sep 04 00:56 UTC	PCG Pacific Gas & Electric	◎ Target	Barclays	Nicholas Campanella ★☆☆☆☆ #3048	Overweight	$23.00→ $18.00-21.7%
Sep 04 00:56 UTC	PATH UiPath	◎ Target	Needham & Company LLC	Scott Berg ★★★☆☆ #1589	Buy	$15.00→ $22.00+46.7%
Sep 04 00:56 UTC	PAGP Plains GP	◎ Target	JPMorgan Chase & Co.	Jeremy Tonet ★★☆☆☆ #2498	Neutral	$24.00→ $27.00+12.5%
Sep 04 00:56 UTC	PAA Plains All American Pipeline	◎ Target	JPMorgan Chase & Co.	Jeremy Tonet ★★☆☆☆ #2498	Neutral	$24.00→ $27.00+12.5%
Sep 04 00:56 UTC	ON onsemi	◎ Target	Wells Fargo & Company	Joe Quatrochi not yet tracked	Overweight	$110.00→ $95.00-13.6%
Sep 04 00:56 UTC	OLLI Ollie's Bargain Outlet	◎ Target	Truist Financial	Scot Ciccarelli ★★★☆☆ #1192	Buy	$80.00→ $85.00+6.2%
Sep 04 00:56 UTC	OLLI Ollie's Bargain Outlet	◎ Target	The Goldman Sachs Group	Kate McShane ★★★☆☆ #1827	Buy	$112.00→ $100.00-10.7%
Sep 04 00:56 UTC	OLLI Ollie's Bargain Outlet	◎ Target	Morgan Stanley	Simeon Gutman ★★☆☆☆ #2667	Equal Weight	$108.00→ $98.00-9.3%
Sep 04 00:56 UTC	OLLI Ollie's Bargain Outlet	◎ Target	Royal Bank Of Canada	Steven Shemesh ★★☆☆☆ #2410	Outperform	$121.00→ $124.00+2.5%
Sep 04 00:56 UTC	OLLI Ollie's Bargain Outlet	◎ Target	Wells Fargo & Company	Edward Kelly ★★★☆☆ #2139	Overweight	$100.00→ $90.00-10.0%
Sep 04 00:56 UTC	OKE ONEOK	◎ Target	Citigroup	Spiro Dounis not yet tracked	Buy	$97.00→ $108.00+11.3%
Sep 04 00:56 UTC	NTSK Netskope	◎ Target	Robert W. Baird	Shrenik Kothari ★★★☆☆ #1193	Outperform	$18.00→ $20.00+11.1%
Sep 04 00:56 UTC	NTSK Netskope	◎ Target	BTIG Research	Gray Powell ★★★☆☆ #1092	Buy	$17.00→ $18.00+5.9%
Sep 04 00:56 UTC	NTSK Netskope	◎ Target	Royal Bank Of Canada	Matthew Hedberg ★★★☆☆ #1799	Outperform	$18.00→ $20.00+11.1%
Sep 04 00:56 UTC	NTSK Netskope	◎ Target	Rosenblatt Securities	Catharine Trebnick ★★★☆☆ #2015	Buy	$18.00→ $19.00+5.6%
Sep 04 00:56 UTC	NTSK Netskope	◎ Target	JPMorgan Chase & Co.	Brian Essex ★★★☆☆ #1766	Overweight	$16.00→ $18.00+12.5%
Sep 04 00:56 UTC	NTSK Netskope	◎ Target	Piper Sandler	Rob Owens ★★★☆☆ #1234	Overweight	$18.00→ $20.00+11.1%
Sep 04 00:56 UTC	NTSK Netskope	◎ Target	Morgan Stanley	Meta Marshall ★★★★☆ #830	Overweight	$14.00→ $16.00+14.3%
Sep 04 00:56 UTC	NTSK Netskope	◎ Target	BMO Capital Markets	Keith Bachman ★★★☆☆ #1510	Outperform	$13.00→ $18.00+38.5%
Sep 04 00:56 UTC	NTAP NetApp	◎ Target	Northland Securities	Nehal Chokshi ★★★☆☆ #2257	Outperform	$171.00→ $187.00+9.4%
Sep 04 00:56 UTC	NTAP NetApp	◎ Target	UBS Group	David Vogt ★★☆☆☆ #2325	Neutral	$160.00→ $171.00+6.9%
Sep 04 00:56 UTC	NTAP NetApp	◎ Target	Barclays	Tim Long ★★☆☆☆ #2632	Overweight	$199.00→ $219.00+10.1%
Sep 04 00:56 UTC	NTAP NetApp	◎ Target	Wells Fargo & Company	Aaron Rakers ★★★☆☆ #2128	Equal Weight	$180.00→ $190.00+5.6%
Sep 04 00:56 UTC	NTAP NetApp	◎ Target	Susquehanna	Mehdi Hosseini ★★★☆☆ #1126	Neutral	$185.00→ $195.00+5.4%
Sep 04 00:56 UTC	NTAP NetApp	◎ Target	Wedbush	Matt Bryson ★★★☆☆ #1482	Neutral	$150.00→ $170.00+13.3%
Sep 04 00:56 UTC	NTAP NetApp	◎ Target	Morgan Stanley	Erik Woodring ★★☆☆☆ #2278	Equal Weight	$173.00→ $191.00+10.4%
Sep 04 00:56 UTC	NTAP NetApp	◎ Target	Citigroup	Asiya Merchant ★★★☆☆ #1873	Neutral	$209.00→ $190.00-9.1%
Sep 04 00:56 UTC	NBIX Neurocrine Biosciences	◎ Target	Citigroup	Yigal Nochomovitz ★☆☆☆☆ #3043	Buy	$249.00→ $253.00+1.6%
Sep 04 00:56 UTC	NAKA KindlyMD	◎ Target	B. Riley Financial	Fedor Shabalin ★☆☆☆☆ #2920	Buy	$9.00→ $11.00+22.2%
Sep 04 00:56 UTC	NA National Bank of Canada	◎ Target	Jefferies Financial Group	firm only		C$212.00→ C$213.00+0.5%
Sep 04 00:56 UTC	NA National Bank of Canada	◎ Target	Canaccord Genuity Group	firm only		C$224.00→ C$228.00+1.8%
Sep 04 00:56 UTC	NA National Bank of Canada	◎ Target	Canadian Imperial Bank of Commerce	firm only	Outperformer	C$249.00→ C$242.00-2.8%
Sep 04 00:56 UTC	MSTR Strategy	◎ Target	B. Riley Financial	Fedor Shabalin ★☆☆☆☆ #2920	Buy	$155.00→ $175.00+12.9%
Sep 04 00:56 UTC	MPC Marathon Petroleum	◎ Target	Piper Sandler	John Royall not yet tracked	Overweight	$344.00→ $462.00+34.3%
Sep 04 00:56 UTC	MMED MiniMed Group	◎ Target	Morgan Stanley	Kallum Titchmarsh ★★★★☆ #915	Overweight	$19.00→ $21.00+10.5%
Sep 04 00:56 UTC	MGNI Magnite	◎ Target	Needham & Company LLC	Laura Martin ★★☆☆☆ #2845	Buy	$25.00→ $30.00+20.0%
Sep 04 00:56 UTC	MDT Medtronic	◎ Target	UBS Group	Priya Sachdeva not yet tracked	Buy	$100.00→ $110.00+10.0%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Rating Changes

Frequently Asked Questions

Welcome to 13Foresight!